United States: Limits Of PTAB Sovereign Immunity Defense For IPRs Shown In Reactive Surfaces V. Toyota

On July 13, 2017, in Reactive Surfaces Ltd., LLP v. Toyota Motor Corp., the Patent and Trial Appeal Board ("PTAB" or "Board") granted in part a motion to dismiss based on sovereign immunity in an inter partes review ("IPR") proceeding. The order dismissed one of the patent-in-suit's owners—the Regents of the University of Minnesota—but denied the motion to dismiss as to the patent's co-owner Toyota Motor Corp.("Toyota").1 The PTAB recently considered the issue of sovereign immunity in two other decisions: Covidien LP v. University of Florida Research Foundation Inc. and Neochord, Inc. v. University of Maryland, Baltimore.2 As discussed below, these three decisions suggest3 some of the boundaries for applying an Eleventh Amendment sovereign immunity defense in an IPR when public universities are patent owners.

In this case, Reactive Surfaces filed a Petition seeking an IPR of claims 1-11 of U.S. Patent No. 8,394,618, which is co-owned by both Toyota and the Regents of the University of Minnesota ("the Regents") (collectively, "Patent Owners"). As background, the '618 patent was issued listing six inventors. Three of the inventors had assigned their interests to the Regents, and the remaining inventors assigned their interests to Toyota.

The Patent Owners requested a conference call with the Board to request authorization to file a motion to dismiss the Petition on the grounds that the Regents were entitled to sovereign immunity under the Eleventh Amendment, and that this proceeding could not continue without the Regents. After the Board authorized briefing, the Patent Owners filed their motion, arguing that sovereign immunity applied, the Regents were entitled to assert this immunity, and the merits of the IPR could not be adjudicated without the Regents as a party so the IPR should be dismissed in its entirety. After considering the papers submitted by the parties, the Board cited Neochord and Covidien to decide that while "neither of those decisions is binding on us . . . their reasoning [is] persuasive" and, accordingly, Eleventh Amendment sovereign immunity may be invoked as a defense. The Board then concluded "that the Regents cannot be compelled to join this proceeding against their will," but decided that the proceeding could continue without the Regents and, thus, denied the motion to dismiss as to Toyota.

First, the Board addressed the issue of whether a state may assert Eleventh Amendment immunity in an IPR proceedings. Like the panels in Neochord and Covidien, the Board took note of the Supreme Court's decision in Federal Maritime Commission v. South Carolina State Ports Authority ("FMC"), which decided in a different context that "the Eleventh Amendment extends to agency proceedings that 'walk[], talk[], and squawk[] very much like a lawsuit.'"4 The Board also noted the analysis from FMC had been applied to interference proceedings at the PTAB's predecessor, the Board of Patent Appeals and Interferences.5 Similar to Neochord, the Board noted that the procedures for IPRs resemble those used in interferences, explaining that "[a]s with interferences, [IPRs] generally involve adverse parties; provide for examination and cross-examination of witnesses; and result in findings by an impartial federal adjudicator and decisions that the agency has the power to implement" (internal citations omitted). However, the Board stated that IPRs are not the same as lawsuits—"the test for Eleventh Amendment applicability does not require identity with civil litigation in all respects . . . [and] [i]nstead . . . requires similarity in 'Rules of Practice and Procedure,' 'discovery,' and 'the role of the . . . impartial officer designated to hear a case.'" Since these similarities were present in IPR proceedings, the Board found that the Eleventh Amendment immunity extended to the proceedings.

Reactive Surfaces also argued that sovereign immunity did not apply since the language of 35 U.S.C. § 311 suggests that an IPR is a challenge to the patent, not the patent owner, and therefore is a proceeding in rem and not a proceeding in personam. In rejecting the argument, the Board found that characteristics of IPRs that "give them some features of in rem actions" in civil litigation were not enough to "transform" IPR proceedings "into purely administrative proceedings in rem." Because the presence of some "adjudicatory characteristics" made agency proceedings similar to civil litigation, the Board concluded that it was more likely that IPRs "have sufficient in personam character" to apply the Eleventh Amendment and determined sovereign immunity could be asserted in IPR proceedings. The Board further stated that while Congress could revoke sovereign immunity or this immunity could be waived by a state, neither party had raised such an argument.

The Board also considered whether the Regents were capable of asserting a sovereign immunity defense as a state agent or instrumentality of the State of Minnesota. The Board noted that the Eleventh Amendment includes not only actions where a state is named as a defendant but also can include certain actions against state instrumentalities and state agents. Here, the Board recognized that federal and Minnesota state courts "treat the Regents and the University of Minnesota as interchangeable for purposes of the Eleventh Amendment analysis," which "strongly suggests that [the PTAB] should treat the Regents as an arm of the State of Minnesota." Thus, the Board found that the Regents were an arm of the State of Minnesota for purposes of Eleventh Amendment immunity and dismissed the Regents from the proceeding.

Lastly, the Board addressed whether the IPR proceeding could continue if the Regents were no longer a part of the proceeding. The Patent Owners argued that there should be a rule requiring automatic termination of a proceeding when the dismissal of a party is on the basis of sovereign immunity. However, the Board noted that federal courts that considered this issue had not "applied a bright-line rule that requires dismissal of any action after a finding that one defendant has sovereign immunity"; "[i]nstead, when the absent sovereign party and a remaining party have identical 'interests in the asserted patents,' the remaining party adequately represents the interests of the absent sovereign party under Rule 19(b)(1)." Here, the Board noted that even with the Regents dismissed from the proceeding, the other patent owner was present and found that both "[t]he present patent owner[, Toyota,] and the absent patent owner[, the Regents,] both hold identical interests" in the asserted patent. For this reason, the Board held that Toyota would adequately represent the interests of the Regents and the IPR could proceed in their absence. As a result of these findings, the Board dismissed the Regents but did not dismiss co-owner Toyota.

This is the third decision recently in which the PTAB considered the defense of sovereign immunity in IPR proceedings. The first decision addressing whether sovereign immunity was applicable in an IPR was Covidien, which granted the University of Florida Research Foundation's motion to dismiss several IPR petitions. In that case, the university was the only party.

In the second decision, Neochord, patent-owner University of Maryland, Baltimore, and its exclusive licensee filed a motion to dismiss after the IPR was instituted and shortly before oral argument was to be heard on the merits. In that case, the PTAB determined that sovereign immunity applied to the university and that "the University retained rights under the license agreement, and transferred less than 'substantially all' of its rights to [the licensee]." Thus, the Neochord panel found that the IPR could not proceed without the university because it "remained a necessary and indispensable party to [the] proceeding." Accordingly, both the university and the exclusive licensee were dismissed.

In summary, Covidien, Neochord, and Reactive Surfaces all involved public universities who, directly or indirectly, were patent owners that asserted sovereign immunity under the Eleventh Amendment in IPR proceedings. In each case, the PTAB dismissed the universities based on sovereign immunity. However, when other parties also had rights to the patent-in-suit-i.e., the exclusive licensee in Neochord and co-owner Toyota in Reactive Surfaces—the PTAB arrived at different conclusions about whether the IPR could be dismissed in its entirety. The distinction that the PTAB seems to have drawn is based on whether the parties' interests to the patent are "identical." In this case, because the co-owners held "identical" interests, the PTAB decided that the IPR could proceed against Toyota even after dismissing the university—which, as a co-owner, still bore the risk of having its rights extinguished in the proceeding despite having sovereign immunity. But in Neochord, the university's retention of rights to an exclusively licensed patent was the basis to dismiss both the licensee and the university because their interests were not identical.

As of this writing, the Federal Circuit has not weighed in on the merits of any of these dismissals. Consequently, the PTAB's panel decisions are the only guidance available. Licensees and co-owners of patents owned by universities, as well as petitioners filing IPRs against such patents, should take note of the PTAB's disparate treatment of these different factual situations.


1 Reactive Surfaces Ltd. v. Toyota Motor Corp., No. IPR2016-1914 (P.T.A.B. July 13, 2017) (Paper 36).
2 Covidien LP v. Univ. of Fla. Research Found. Inc., No. IPR2016-1274 (P.T.A.B. Jan. 25, 2017) (Paper 21); Neochord, Inc. v. Univ. of Md., Baltimore, No. IPR2016-208 (P.T.A.B. May 23, 2017) (Paper 28).
3 As of this writing, the PTAB has not designated any of these decisions as Precedential or even Informative, thus none of the decisions is binding and it is instead left to a PTAB panel to "find their reasoning persuasive." See Reactive Surfaces, No. IPR2016-1914, slip op. at 4; United States Patent and Trademark Office, List of Precedential Opinions, https://www.uspto.gov/patents-application-process/appealing-patent-decisions/decisions-and-opinions/precedential (last visited July 24, 2017); United States Patent and Trademark Office, List of Informative Opinions, https://www.uspto.gov/patents-application-process/appealing-patent-decisions/decisions-and-opinions/informative-opinions-0 (last visited July 24, 2017);.
4 Fed. Maritime Comm'n v. S.C. State Ports Auth., 535 U.S. 743, 756-59 (2002).
5 See Vas-Cath, Inc. v. Univ. of Mo., 473 F.3d 1376, 1382 (Fed. Cir. 2007).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Marshall, Gerstein & Borun LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Marshall, Gerstein & Borun LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions